Tumor endothelial marker 8 expression in triple-negative breast cancer

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3417-3422

  Gutwein, Luke G ^a   Al Quran, Samer Z ^b   Fernando, Stephen ^a   Fletcher, Bradley S ^a   Copeland, Edward M ^a   Grobmyer, Stephen R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Breast cancer; Immunohistochemistry; Lymph node metastasis; TEM8; Triple negative breast cancer

Indexed keywords

GLYCOPROTEIN; TUMOR ENDOTHELIAL MARKER 8; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST; CANCER TISSUE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOID TISSUE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TRIPLE NEGATIVE BREAST CANCER;

ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 80054729708     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Foulkes WD, Smith IE and Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 363: 1938-1948, 2010.
2. Bosch A, Eroles P, Zaragoza R, Vina JR and Lluch A: Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 36: 206-215, 2010.
3. Chacon RD and Costanzo MV: Triple-negative breast cancer. Breast Cancer Res 12(Suppl 2): S3 2010.
4. De Laurentiis M, Cianniello D, Caputo R, Stanzione B, Arpino G, Cinieri S, Lorasso V and De Placido S: Treatment of triple-negative breast cancer (TNBC): current options and future perspectives. Cancer Treat Rev 36(Suppl 3): S80-86, 2010.
5. Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U and Harbeck N: Triple-negative breast cancer current status and future directions. Ann Oncol 20: 1913-1927, 2009.
6. St. Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinsler KW: Genes expressed in human tumor endothelium. Science 289: 1197-1202, 2000. (Pubitemid 30650733)
7. Fernando S and Fletcher BS: Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice. Cancer Res 69: 5126-5132, 2009.
8. Davies G, Cunnick GH, Mansel RE, Mason MD and Jiang WG: Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 27: 31-37, 2004. (Pubitemid 38365655)
9. Davies G, Rmali KA, Watkins G, Mansel RE, Mason MD and Jiang WG: Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. Int J Oncol 29: 1311-1317, 2006.
10. Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW and St. Croix B: TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res 64: 817-820, 2004. (Pubitemid 38176877)
11. Duan HF, Hu XW, Chen JL, Gao LH, Xi YY, Lu Y, Li JF, Zhao SR, Xu JJ, Chen HP and Wu CT: Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8. J Natl Cancer Inst 99: 1551-1555, 2007. (Pubitemid 351767233)
12. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW and St Croix B: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61: 6649-6655, 2001. (Pubitemid 32896479)
13. Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP and Terman BI: TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 305: 133-144, 2005. (Pubitemid 40380660)
14. Cullen M, Seaman S, Chaudhary A, Yang MY, Hilton MB, Logsdon D, Haines DC, Tessarollo L and St. Croix B: Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res 69: 6021-6026, 2009.
15. Ruan Z, Yang Z, Wang Y, Wang H, Chen Y, Shang X, Yang C, Guo S, Han J, Liang H and Wu Y: DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth. J Immunother 32: 486-491, 2009.
16. Felicetti P, Mennecozzi M, Barucca A, Montgomery S, Orlandi F, Manova K, Houghton AN, Gregor PD, Concetti A and Venanzi FM: Tumor endothelial marker 8 enhances tumor immunity in conjunction with immnization against differentiation Ag. Cytotherapy 9: 23-34, 2007.
17. Yang MY, Chaudhary A, Seaman S, Dunty J, Stevens J, Elzarrad MK, Frankel AE and St Croix B: The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim Biophys Acta 1813: 39-49, 2011.
18. Grobmyer SR, Morse DL, Fletcher B, Gutwein LG, Sharma P, Krishna V, Frost SC, Moudgil BM and Brown SC: The promise of nanotechnology for solving clinical problems in breast cancer. J Surg Oncol 103: 317-325, 2011.